Factor XIIIa supports microvascular endothelial cell adhesion and inhibits capillary tube formation in fibrin

被引:32
作者
Dallabrida, SM
Falls, LA
Farrell, DH
机构
[1] Oregon Hlth & Sci Univ, Sch Dent, Dept Oral Mol Biol, Portland, OR 97201 USA
[2] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA
[3] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA
[4] Beth Israel Deaconess Med Ctr, Ctr Hemostasis & Thrombosis Res, Boston, MA USA
[5] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1182/blood.V95.8.2586.008k04_2586_2592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coagulation factor XIIIa is a transglutaminase that catalyzes covalent cross-link formation in fibrin clots. In this report, we demonstrate that factor XIIIa also mediates adhesion of endothelial cells and inhibits capillary tube formation in fibrin, The adhesive activity of factor XIIIa was not dependent on the transglutaminase activity, and did not involve the factor XIIIb-subunits. The adhesion was inhibited by 99% using a combination of monoclonal antibodies directed against integrin alpha(v)beta(3) and beta(1)-containing integrins, and was dependent on Mg2+ or Mn2+. Soluble factor XIIIa also bound to endothelial cells in solution, as detected by flow cytometry, In addition, factor XIIIa inhibited endothelial cell capillary tube formation in fibrin in a dose-dependent manner. Furthermore, the extent of inhibition differed in 2 types of fibrin, The addition of 10 to 100 mu g/mL factor XIIIa produced a dose-dependent reduction in capillary tube formation of 60% to 100% in gamma A/gamma A fibrin, but only a 10% to 37% decrease in gamma A/gamma' fibrin, These results show that factor XIIIa supports endothelial cell adhesion in an integrin-dependent manner and inhibits capillary tube formation. (Blood.2000;95:2586-2592) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:2586 / 2592
页数:7
相关论文
共 54 条
[11]   FACTOR XIIIA BINDING TO ACTIVATED PLATELETS IS MEDIATED THROUGH ACTIVATION OF GLYCOPROTEIN IIB-IIIA [J].
COX, AD ;
DEVINE, DV .
BLOOD, 1994, 83 (04) :1006-1016
[12]   ALPHA-CHAIN DOMAIN OF FIBRINOGEN CONTROLS GENERATION OF FIBRINOLIGASE (COAGULATION FACTOR-XIIIA) - CALCIUM-ION REGULATORY ASPECTS [J].
CREDO, RB ;
CURTIS, CG ;
LORAND, L .
BIOCHEMISTRY, 1981, 20 (13) :3770-3778
[13]  
DEJANA E, 1988, BLOOD, V71, P566
[14]   PLATELET-ASSOCIATED FACTOR-XIII AS A MARKER OF PLATELET ACTIVATION IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE [J].
DEVINE, DV ;
ANDESTAD, G ;
NUGENT, D ;
CARTER, CJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (06) :857-862
[15]   DOCUMENTATION OF PLASMA FACTOR XIII DEFICIENCY IN MAN [J].
DUCKERT, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1972, 202 (DEC8) :190-199
[16]  
Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97
[17]   Resistance of gamma A/gamma' fibrin clots to fibrinolysis [J].
Falls, LA ;
Farrell, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14251-14256
[18]   ROLE OF FIBRINOGEN ALPHA-CHAIN AND GAMMA-CHAIN SITES IN PLATELET-AGGREGATION [J].
FARRELL, DH ;
THIAGARAJAN, P ;
CHUNG, DW ;
DAVIE, EW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10729-10732
[19]   RECOMBINANT HUMAN FIBRINOGEN AND SULFATION OF THE GAMMA' CHAIN [J].
FARRELL, DH ;
MULVIHILL, ER ;
HUANG, SM ;
CHUNG, DW ;
DAVIE, EW .
BIOCHEMISTRY, 1991, 30 (39) :9414-9420
[20]  
FARRELL DH, 1994, J BIOL CHEM, V269, P226